154 related articles for article (PubMed ID: 130347)
1. A cost-effectiveness model for evaluating health care programs: application to drug abuse treatment.
Goldschmidt PG
Inquiry; 1976 Mar; 13(1):29-47. PubMed ID: 130347
[No Abstract] [Full Text] [Related]
2. Evaluation of treatment for drug abuse.
Sells SB
Proc Natl Conf Methadone Treat; 1973; 2():1362-8. PubMed ID: 4808289
[No Abstract] [Full Text] [Related]
3. Evaluating drug abuse treatment: a comment on the state of the art.
Jaffe JH
NIDA Res Monogr; 1984; 51():13-28. PubMed ID: 6095081
[No Abstract] [Full Text] [Related]
4. The effectiveness of drug treatment.
Gerstein DR
Res Publ Assoc Res Nerv Ment Dis; 1992; 70():253-82. PubMed ID: 1311121
[No Abstract] [Full Text] [Related]
5. The cost-effectiveness of methadone maintenance.
Barnett PG; Hui SS
Mt Sinai J Med; 2000; 67(5-6):365-74. PubMed ID: 11064486
[TBL] [Abstract][Full Text] [Related]
6. Newer treatment approaches for drug addiction.
Conrad HT
Med Arts Sci; 1971; 25(1):15-32. PubMed ID: 5155704
[No Abstract] [Full Text] [Related]
7. Phoenix House: an interview with Mitchell S. Rosenthal.
Sharaf MR
Semin Psychiatry; 1971 Feb; 3(1):226-44. PubMed ID: 5173040
[No Abstract] [Full Text] [Related]
8. Drug abuse programs: are hospitals too late and too square?
Philips DF
Hospitals; 1971 Jan; 45(2):55-60. PubMed ID: 5123315
[No Abstract] [Full Text] [Related]
9. Evaluation and referral of drug abusers within business settings.
Kiev A
J Occup Med; 1973 Jan; 15(1):23-5. PubMed ID: 4684724
[No Abstract] [Full Text] [Related]
10. On the effectiveness of treatment for drug abuse: evidence from the DARP research programme in the United States.
Sells SB; Simpson DD
Bull Narc; 1979; 31(1):1-11. PubMed ID: 260891
[No Abstract] [Full Text] [Related]
11. Hospitals coordinate chemical abuse programs.
Malloy JM
Hospitals; 1974 Oct; 48(20):59-62. PubMed ID: 4413701
[No Abstract] [Full Text] [Related]
12. Treatment facilities for drug-dependent patients. Some impressions of treatment programmes in the United States and Canada.
Jensen GR
Med J Aust; 1973 Apr; 1(16):808-12. PubMed ID: 4707801
[No Abstract] [Full Text] [Related]
13. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
14. Heroin addiction: a treatable disease.
Krepick DS; Long BL
Nurs Clin North Am; 1973 Mar; 8(1):41-52. PubMed ID: 4487808
[No Abstract] [Full Text] [Related]
15. The costs of crime and the benefits of drug abuse treatment: a cost-benefit analysis using TOPS data.
Harwood HJ; Hubbard RL; Collins JJ; Rachal JV
NIDA Res Monogr; 1988; 86():209-35. PubMed ID: 3140032
[No Abstract] [Full Text] [Related]
16. Methadone treatment versus therapeutic communities: preliminary results of a randomized study in progress.
Bale RN; Van Stone WW; Kuldau JM; Engelsing TM; Zarcone VP
Proc Natl Conf Methadone Treat; 1973; 2():1027-34. PubMed ID: 4808243
[No Abstract] [Full Text] [Related]
17. The natural history of narcotic drug addiction.
Vaillant GE
Semin Psychiatry; 1970 Nov; 2(4):486-98. PubMed ID: 5527413
[No Abstract] [Full Text] [Related]
18. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
Woodward AM; Raskin IE; Blacklow B
Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
[TBL] [Abstract][Full Text] [Related]
19. [Social and medical assistance for drug addicts].
Marinelli M; Fresa U; D'Agostino M; Ruoppo G
Arch Monaldi; 1981; 36(1-2):3-8. PubMed ID: 6982695
[No Abstract] [Full Text] [Related]
20. Evaluation of drug abuse treatment and rehabilitation programs.
Doran R
Proc Natl Conf Methadone Treat; 1973; 2():1374-8. PubMed ID: 4808291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
